Utilizing Multiomic Advanced Diagnostics to Identify CDK 4/6 Inhibitor Response Predictors and a Post-treatment Multiomic Signature for Patients With ER+/HER2- Metastatic Breast Cancer
Clinical trial NCT03195192 · COMPLETED
Trial details
- NCT number
- NCT03195192
- Sponsor
- Side-Out Foundation
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-09
- Primary completion
- 2020-06-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.